Novel motif:160: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:25, 9 September 2013
name: | motif160_AGCCGGTAACG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0034470 | ncRNA processing | 4.344377e-17 |
GO:0030433 | ER-associated protein catabolic process | 1.903049e-16 |
GO:0034660 | ncRNA metabolic process | 1.757141e-10 |
GO:0019048 | virus-host interaction | 4.008802e-10 |
GO:0043508 | negative regulation of JUN kinase activity | 1.933343e-9 |
GO:0006354 | transcription elongation, DNA-dependent | 2.176471e-9 |
GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 6.555958e-9 |
GO:0006364 | rRNA processing | 6.606934e-9 |
GO:0016072 | rRNA metabolic process | 7.154769e-9 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 9.826669e-9 |
GO:0035461 | vitamin transmembrane transport | 1.770679e-8 |
GO:0008033 | tRNA processing | 3.642143e-8 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 5.850202e-8 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 6.386994e-8 |
GO:0031284 | positive regulation of guanylate cyclase activity | 6.456523e-8 |
GO:0006396 | RNA processing | 7.564045e-8 |
GO:0071071 | regulation of phospholipid biosynthetic process | 9.033158e-8 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.009792e-7 |
GO:0018205 | peptidyl-lysine modification | 1.086986e-7 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 1.561819e-7 |
GO:0042254 | ribosome biogenesis | 1.586050e-7 |
GO:0006298 | mismatch repair | 1.955566e-7 |
GO:0010498 | proteasomal protein catabolic process | 4.301472e-7 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 4.529381e-7 |
GO:0016570 | histone modification | 4.629980e-7 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 6.113886e-7 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 6.583414e-7 |
GO:0010544 | negative regulation of platelet activation | 1.417576e-6 |
GO:0016569 | covalent chromatin modification | 1.640728e-6 |
GO:0016140 | O-glycoside metabolic process | 2.250466e-6 |
GO:0033326 | cerebrospinal fluid secretion | 2.335795e-6 |
GO:0045901 | positive regulation of translational elongation | 3.333557e-6 |
GO:0045905 | positive regulation of translational termination | 3.333557e-6 |
GO:0006452 | translational frameshifting | 3.333557e-6 |
GO:0001522 | pseudouridine synthesis | 3.367032e-6 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 3.399030e-6 |
GO:0097039 | protein linear polyubiquitination | 3.631034e-6 |
GO:0019087 | transformation of host cell by virus | 4.137137e-6 |
GO:0021986 | habenula development | 4.578735e-6 |
GO:2000009 | negative regulation of protein localization at cell surface | 4.702504e-6 |
GO:0016032 | viral reproduction | 5.250975e-6 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 8.703579e-6 |
GO:0070078 | histone H3-R2 demethylation | 9.245396e-6 |
GO:0070079 | histone H4-R3 demethylation | 9.245396e-6 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 9.245396e-6 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 1.068671e-5 |
GO:0033145 | positive regulation of steroid hormone receptor signaling pathway | 1.200342e-5 |
GO:0008612 | peptidyl-lysine modification to hypusine | 1.251759e-5 |
GO:0070286 | axonemal dynein complex assembly | 1.307788e-5 |
GO:0051168 | nuclear export | 1.376310e-5 |
GO:0033148 | positive regulation of estrogen receptor signaling pathway | 1.382732e-5 |
GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | 1.716073e-5 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 1.835988e-5 |
GO:0006325 | chromatin organization | 1.873168e-5 |
GO:0034224 | cellular response to zinc ion starvation | 2.129747e-5 |
GO:0031282 | regulation of guanylate cyclase activity | 2.138600e-5 |
GO:0071934 | thiamine transmembrane transport | 2.433302e-5 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.532473e-5 |
GO:0006901 | vesicle coating | 2.680001e-5 |
GO:0010734 | negative regulation of protein glutathionylation | 2.926596e-5 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 2.937991e-5 |
GO:0019060 | intracellular transport of viral proteins in host cell | 2.985483e-5 |
GO:0009450 | gamma-aminobutyric acid catabolic process | 3.288511e-5 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 3.633406e-5 |
GO:0003290 | atrial septum secundum morphogenesis | 3.938880e-5 |
GO:0043084 | penile erection | 3.983361e-5 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 4.919487e-5 |
GO:0061157 | mRNA destabilization | 4.919487e-5 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 4.919487e-5 |
GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response | 5.096477e-5 |
GO:0006473 | protein acetylation | 5.114891e-5 |
GO:0033146 | regulation of estrogen receptor signaling pathway | 5.141475e-5 |
GO:2000369 | regulation of clathrin-mediated endocytosis | 5.145084e-5 |
GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 5.513963e-5 |
GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 5.513963e-5 |
GO:0048194 | Golgi vesicle budding | 5.737569e-5 |
GO:0006900 | membrane budding | 5.774847e-5 |
GO:0008634 | negative regulation of survival gene product expression | 6.072824e-5 |
GO:0016568 | chromatin modification | 6.078076e-5 |
GO:0043543 | protein acylation | 6.188731e-5 |
GO:0016567 | protein ubiquitination | 6.192711e-5 |
GO:0021903 | rostrocaudal neural tube patterning | 7.138913e-5 |
GO:0000183 | chromatin silencing at rDNA | 7.709563e-5 |
GO:0016573 | histone acetylation | 8.011894e-5 |
GO:0006457 | protein folding | 8.033777e-5 |
GO:0006611 | protein export from nucleus | 8.147213e-5 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 8.289244e-5 |
GO:0050434 | positive regulation of viral transcription | 8.650573e-5 |
GO:0018394 | peptidyl-lysine acetylation | 8.684696e-5 |
GO:0000212 | meiotic spindle organization | 8.748649e-5 |
GO:0006083 | acetate metabolic process | 8.903621e-5 |
GO:0070647 | protein modification by small protein conjugation or removal | 8.968715e-5 |
GO:0006348 | chromatin silencing at telomere | 9.248382e-5 |
GO:0006449 | regulation of translational termination | 9.574379e-5 |
GO:0042274 | ribosomal small subunit biogenesis | 9.801956e-5 |
GO:2000370 | positive regulation of clathrin-mediated endocytosis | 1.041115e-4 |
GO:0006475 | internal protein amino acid acetylation | 1.225560e-4 |
GO:0016142 | O-glycoside catabolic process | 1.243808e-4 |
GO:0014813 | satellite cell commitment | 1.243808e-4 |
GO:0002882 | positive regulation of chronic inflammatory response to non-antigenic stimulus | 1.243808e-4 |
GO:0032314 | regulation of Rac GTPase activity | 1.268487e-4 |
GO:0010823 | negative regulation of mitochondrion organization | 1.305064e-4 |
GO:0045007 | depurination | 1.314998e-4 |
GO:0009785 | blue light signaling pathway | 1.340090e-4 |
GO:0018393 | internal peptidyl-lysine acetylation | 1.450684e-4 |
GO:0046390 | ribose phosphate biosynthetic process | 1.599018e-4 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.671597e-4 |
GO:0001661 | conditioned taste aversion | 1.745639e-4 |
GO:0018027 | peptidyl-lysine dimethylation | 1.798016e-4 |
GO:0046293 | formaldehyde biosynthetic process | 1.919381e-4 |
GO:0016246 | RNA interference | 2.055985e-4 |
GO:0015887 | pantothenate transmembrane transport | 2.164427e-4 |
GO:0015878 | biotin transport | 2.164427e-4 |
GO:0009650 | UV protection | 2.317901e-4 |
GO:0042273 | ribosomal large subunit biogenesis | 2.339493e-4 |
GO:0032205 | negative regulation of telomere maintenance | 2.440035e-4 |
GO:0008298 | intracellular mRNA localization | 2.646169e-4 |
GO:0072553 | terminal button organization | 2.649933e-4 |
GO:0061084 | negative regulation of protein refolding | 2.707333e-4 |
GO:2000210 | positive regulation of anoikis | 2.744373e-4 |
GO:0032042 | mitochondrial DNA metabolic process | 2.747731e-4 |
GO:0097151 | positive regulation of inhibitory postsynaptic membrane potential | 2.778688e-4 |
GO:0033617 | mitochondrial respiratory chain complex IV assembly | 2.807261e-4 |
GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process | 2.838007e-4 |
GO:0090083 | regulation of inclusion body assembly | 2.934874e-4 |
GO:0014040 | positive regulation of Schwann cell differentiation | 2.973081e-4 |
GO:0046521 | sphingoid catabolic process | 3.116628e-4 |
GO:0045342 | MHC class II biosynthetic process | 3.116727e-4 |
GO:0070839 | divalent metal ion export | 3.116727e-4 |
GO:0006876 | cellular cadmium ion homeostasis | 3.116727e-4 |
GO:0043091 | L-arginine import | 3.116727e-4 |
GO:0032632 | interleukin-3 production | 3.116727e-4 |
GO:0015707 | nitrite transport | 3.116727e-4 |
GO:0072668 | tubulin complex biogenesis | 3.188230e-4 |
GO:0032446 | protein modification by small protein conjugation | 3.215859e-4 |
GO:0006489 | dolichyl diphosphate biosynthetic process | 3.836905e-4 |
GO:0000422 | mitochondrion degradation | 3.850407e-4 |
GO:0000076 | DNA replication checkpoint | 4.188816e-4 |
GO:0048205 | COPI coating of Golgi vesicle | 4.361467e-4 |
GO:0006438 | valyl-tRNA aminoacylation | 4.429707e-4 |
GO:0002309 | T cell proliferation involved in immune response | 4.626995e-4 |
GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 4.954721e-4 |
GO:0070574 | cadmium ion transmembrane transport | 5.128622e-4 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 5.475703e-4 |
GO:0006419 | alanyl-tRNA aminoacylation | 5.560401e-4 |
GO:0090312 | positive regulation of protein deacetylation | 5.901193e-4 |
GO:0046782 | regulation of viral transcription | 5.911221e-4 |
GO:0032786 | positive regulation of transcription elongation, DNA-dependent | 5.971266e-4 |
GO:0031118 | rRNA pseudouridine synthesis | 6.075565e-4 |
GO:0070625 | zymogen granule exocytosis | 6.182249e-4 |
GO:0014895 | smooth muscle hypertrophy | 6.182249e-4 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 6.182249e-4 |
GO:0003106 | negative regulation of glomerular filtration by angiotensin | 6.182249e-4 |
GO:0006742 | NADP catabolic process | 6.182249e-4 |
GO:0000460 | maturation of 5.8S rRNA | 6.211015e-4 |
GO:0072332 | signal transduction by p53 class mediator resulting in induction of apoptosis | 6.232973e-4 |
GO:0030490 | maturation of SSU-rRNA | 6.363204e-4 |
GO:0097084 | vascular smooth muscle cell development | 6.464431e-4 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 6.514643e-4 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 6.514643e-4 |
GO:0046967 | cytosol to ER transport | 6.708293e-4 |
GO:0060520 | activation of prostate induction by androgen receptor signaling pathway | 6.863684e-4 |
GO:0045720 | negative regulation of integrin biosynthetic process | 6.863684e-4 |
GO:0019102 | male somatic sex determination | 6.863684e-4 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 7.104662e-4 |
GO:0017004 | cytochrome complex assembly | 7.587519e-4 |
GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter | 7.677508e-4 |
GO:0010830 | regulation of myotube differentiation | 7.718177e-4 |
GO:0006448 | regulation of translational elongation | 8.000870e-4 |
GO:0035166 | post-embryonic hemopoiesis | 8.018869e-4 |
GO:0007023 | post-chaperonin tubulin folding pathway | 8.018869e-4 |
GO:0006399 | tRNA metabolic process | 8.022868e-4 |
GO:0033590 | response to cobalamin | 8.671467e-4 |
GO:0006117 | acetaldehyde metabolic process | 8.671467e-4 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 8.684473e-4 |
GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 9.642882e-4 |
GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 9.642882e-4 |
GO:0031065 | positive regulation of histone deacetylation | 9.843179e-4 |
GO:0006264 | mitochondrial DNA replication | 9.920338e-4 |
GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway | 9.933368e-4 |
GO:0043248 | proteasome assembly | 1.006660e-3 |
GO:0006313 | transposition, DNA-mediated | 1.028666e-3 |
GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway | 1.031211e-3 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 1.076697e-3 |
GO:0002456 | T cell mediated immunity | 1.116180e-3 |
GO:0071044 | histone mRNA catabolic process | 1.164516e-3 |
GO:0071218 | cellular response to misfolded protein | 1.175580e-3 |
GO:0072333 | signal transduction by p53 class mediator resulting in induction of anoikis | 1.187988e-3 |
GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis | 1.194815e-3 |
GO:0045065 | cytotoxic T cell differentiation | 1.194815e-3 |
GO:0021796 | cerebral cortex regionalization | 1.194815e-3 |
GO:0006097 | glyoxylate cycle | 1.194815e-3 |
GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development | 1.210838e-3 |
GO:0060286 | flagellar cell motility | 1.210838e-3 |
GO:0042270 | protection from natural killer cell mediated cytotoxicity | 1.210838e-3 |
GO:0003061 | positive regulation of the force of heart contraction by norepinephrine | 1.210838e-3 |
GO:0006406 | mRNA export from nucleus | 1.215414e-3 |
GO:0018993 | somatic sex determination | 1.234357e-3 |
GO:0000154 | rRNA modification | 1.234357e-3 |
GO:0042375 | quinone cofactor metabolic process | 1.239740e-3 |
GO:2000209 | regulation of anoikis | 1.267463e-3 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.324647e-3 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.350855e-3 |
GO:0018344 | protein geranylgeranylation | 1.350855e-3 |
GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair | 1.350855e-3 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 1.350945e-3 |
GO:0006491 | N-glycan processing | 1.359317e-3 |
GO:0008078 | mesodermal cell migration | 1.376241e-3 |
GO:0090324 | negative regulation of oxidative phosphorylation | 1.446631e-3 |
GO:0010255 | glucose mediated signaling pathway | 1.446631e-3 |
GO:0009436 | glyoxylate catabolic process | 1.446631e-3 |
GO:0009912 | auditory receptor cell fate commitment | 1.457910e-3 |
GO:0009405 | pathogenesis | 1.496952e-3 |
GO:0009155 | purine deoxyribonucleotide catabolic process | 1.522876e-3 |
GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 1.534147e-3 |
GO:0019478 | D-amino acid catabolic process | 1.571393e-3 |
GO:0070845 | polyubiquitinated misfolded protein transport | 1.600317e-3 |
GO:0002523 | leukocyte migration involved in inflammatory response | 1.645704e-3 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1.716938e-3 |
GO:0030422 | production of siRNA involved in RNA interference | 1.766091e-3 |
GO:0009637 | response to blue light | 1.766091e-3 |
GO:0070904 | transepithelial L-ascorbic acid transport | 1.807065e-3 |
GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 1.865281e-3 |
GO:0034968 | histone lysine methylation | 1.999303e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 2.074139e-3 |
GO:0048050 | post-embryonic eye morphogenesis | 2.122064e-3 |
GO:0070535 | histone H2A K63-linked ubiquitination | 2.156682e-3 |
GO:0002513 | tolerance induction to self antigen | 2.166249e-3 |
GO:0034509 | centromeric core chromatin assembly | 2.168882e-3 |
GO:0030393 | fructoselysine metabolic process | 2.168882e-3 |
GO:0048199 | vesicle targeting, to, from or within Golgi | 2.274124e-3 |
GO:0015822 | ornithine transport | 2.280534e-3 |
GO:0042053 | regulation of dopamine metabolic process | 2.304207e-3 |
GO:0045793 | positive regulation of cell size | 2.318960e-3 |
GO:0001309 | age-dependent telomere shortening | 2.323675e-3 |
GO:0032214 | negative regulation of telomere maintenance via semi-conservative replication | 2.323675e-3 |
GO:0003285 | septum secundum development | 2.371610e-3 |
GO:0060178 | regulation of exocyst localization | 2.383755e-3 |
GO:0001928 | regulation of exocyst assembly | 2.383755e-3 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 2.383755e-3 |
GO:0009303 | rRNA transcription | 2.452059e-3 |
GO:0071415 | cellular response to purine-containing compound | 2.519925e-3 |
GO:0016180 | snRNA processing | 2.539904e-3 |
GO:0070255 | regulation of mucus secretion | 2.616263e-3 |
GO:0000072 | M phase specific microtubule process | 2.740040e-3 |
GO:0046784 | intronless viral mRNA export from host nucleus | 2.762594e-3 |
GO:0060711 | labyrinthine layer development | 2.844084e-3 |
GO:0021932 | hindbrain radial glia guided cell migration | 2.897268e-3 |
GO:0090085 | regulation of protein deubiquitination | 2.910869e-3 |
GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process | 2.930135e-3 |
GO:0000066 | mitochondrial ornithine transport | 2.938384e-3 |
GO:0060586 | multicellular organismal iron ion homeostasis | 3.122111e-3 |
GO:0018026 | peptidyl-lysine monomethylation | 3.190341e-3 |
GO:0071421 | manganese ion transmembrane transport | 3.212097e-3 |
GO:0019941 | modification-dependent protein catabolic process | 3.315647e-3 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 3.330535e-3 |
GO:0050861 | positive regulation of B cell receptor signaling pathway | 3.331248e-3 |
GO:0061050 | regulation of cell growth involved in cardiac muscle cell development | 3.331248e-3 |
GO:0060464 | lung lobe formation | 3.331248e-3 |
GO:0043456 | regulation of pentose-phosphate shunt | 3.385899e-3 |
GO:0015761 | mannose transport | 3.385899e-3 |
GO:0042069 | regulation of catecholamine metabolic process | 3.395810e-3 |
GO:0032792 | negative regulation of CREB transcription factor activity | 3.450385e-3 |
GO:0070534 | protein K63-linked ubiquitination | 3.462204e-3 |
GO:0006290 | pyrimidine dimer repair | 3.463940e-3 |
GO:0050765 | negative regulation of phagocytosis | 3.570860e-3 |
GO:0010701 | positive regulation of norepinephrine secretion | 3.579049e-3 |
GO:0009138 | pyrimidine nucleoside diphosphate metabolic process | 3.579049e-3 |
GO:0071712 | ER-associated misfolded protein catabolic process | 3.591972e-3 |
GO:0051028 | mRNA transport | 3.693387e-3 |
GO:0060263 | regulation of respiratory burst | 3.708808e-3 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 3.738806e-3 |
GO:0008637 | apoptotic mitochondrial changes | 3.746099e-3 |
GO:0090084 | negative regulation of inclusion body assembly | 3.755493e-3 |
GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 3.917707e-3 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 3.945835e-3 |
GO:0009451 | RNA modification | 3.952007e-3 |
GO:0010430 | fatty acid omega-oxidation | 3.983493e-3 |
GO:0090086 | negative regulation of protein deubiquitination | 3.983493e-3 |
GO:0043267 | negative regulation of potassium ion transport | 4.234025e-3 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 4.311077e-3 |
GO:0045116 | protein neddylation | 4.377648e-3 |
GO:0002921 | negative regulation of humoral immune response | 4.397508e-3 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 4.518781e-3 |
GO:0021526 | medial motor column neuron differentiation | 4.518781e-3 |
GO:0043632 | modification-dependent macromolecule catabolic process | 4.567698e-3 |
GO:0021562 | vestibulocochlear nerve development | 4.593056e-3 |
GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway | 4.602169e-3 |
GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 4.637662e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 4.647009e-3 |
GO:0008636 | activation of caspase activity by protein phosphorylation | 4.647009e-3 |
GO:0035409 | histone H3-Y41 phosphorylation | 4.647009e-3 |
GO:0006914 | autophagy | 4.650099e-3 |
GO:0006903 | vesicle targeting | 4.679749e-3 |
GO:0070170 | regulation of tooth mineralization | 4.702702e-3 |
GO:0060535 | trachea cartilage morphogenesis | 4.751699e-3 |
GO:0071542 | dopaminergic neuron differentiation | 4.764497e-3 |
GO:0016073 | snRNA metabolic process | 4.848721e-3 |
GO:0060674 | placenta blood vessel development | 5.045278e-3 |
GO:0050687 | negative regulation of defense response to virus | 5.071678e-3 |
GO:0071480 | cellular response to gamma radiation | 5.128372e-3 |
GO:0002082 | regulation of oxidative phosphorylation | 5.196945e-3 |
GO:0065002 | intracellular protein transmembrane transport | 5.280389e-3 |
GO:0043628 | ncRNA 3'-end processing | 5.280389e-3 |
GO:0010225 | response to UV-C | 5.481551e-3 |
GO:0010025 | wax biosynthetic process | 5.565238e-3 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 5.596225e-3 |
GO:0002121 | inter-male aggressive behavior | 5.685106e-3 |
GO:0009304 | tRNA transcription | 5.859545e-3 |
GO:0016137 | glycoside metabolic process | 5.877795e-3 |
GO:0006405 | RNA export from nucleus | 6.238625e-3 |
GO:0006400 | tRNA modification | 6.372999e-3 |
GO:0019532 | oxalate transport | 6.416779e-3 |
GO:0042772 | DNA damage response, signal transduction resulting in transcription | 6.426724e-3 |
GO:0006281 | DNA repair | 6.476238e-3 |
GO:0016571 | histone methylation | 6.489606e-3 |
GO:0046732 | active induction of host immune response by virus | 6.514198e-3 |
GO:0051567 | histone H3-K9 methylation | 6.525263e-3 |
GO:0009262 | deoxyribonucleotide metabolic process | 6.713035e-3 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 6.811346e-3 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 6.811977e-3 |
GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | 6.923622e-3 |
GO:0060669 | embryonic placenta morphogenesis | 6.967684e-3 |
GO:0060242 | contact inhibition | 6.973185e-3 |
GO:0043173 | nucleotide salvage | 6.973185e-3 |
GO:0008334 | histone mRNA metabolic process | 7.073795e-3 |
GO:0042418 | epinephrine biosynthetic process | 7.090356e-3 |
GO:0042780 | tRNA 3'-end processing | 7.090356e-3 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 7.090356e-3 |
GO:0006713 | glucocorticoid catabolic process | 7.090356e-3 |
GO:0006585 | dopamine biosynthetic process from tyrosine | 7.090356e-3 |
GO:0021771 | lateral geniculate nucleus development | 7.090356e-3 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 7.383969e-3 |
GO:0035967 | cellular response to topologically incorrect protein | 7.443668e-3 |
GO:0010866 | regulation of triglyceride biosynthetic process | 7.460582e-3 |
GO:0031536 | positive regulation of exit from mitosis | 7.590260e-3 |
GO:2001014 | regulation of skeletal muscle cell differentiation | 7.684812e-3 |
GO:0015993 | molecular hydrogen transport | 7.735274e-3 |
GO:0032976 | release of matrix enzymes from mitochondria | 7.833348e-3 |
GO:0046674 | induction of retinal programmed cell death | 7.833348e-3 |
GO:0048597 | post-embryonic camera-type eye morphogenesis | 7.833348e-3 |
GO:0030214 | hyaluronan catabolic process | 7.833348e-3 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 7.833348e-3 |
GO:0021764 | amygdala development | 7.833348e-3 |
GO:0002352 | B cell negative selection | 7.833348e-3 |
GO:0001777 | T cell homeostatic proliferation | 7.833348e-3 |
GO:0001579 | medium-chain fatty acid transport | 7.833348e-3 |
GO:0030854 | positive regulation of granulocyte differentiation | 7.859648e-3 |
GO:0072361 | regulation of glycolysis by regulation of transcription from RNA polymerase II promoter | 8.044339e-3 |
GO:0006463 | steroid hormone receptor complex assembly | 8.044339e-3 |
GO:0032099 | negative regulation of appetite | 8.182828e-3 |
GO:0035522 | monoubiquitinated histone H2A deubiquitination | 8.269579e-3 |
GO:0070682 | proteasome regulatory particle assembly | 8.269579e-3 |
GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity | 8.298431e-3 |
GO:0019408 | dolichol biosynthetic process | 8.429528e-3 |
GO:0007199 | G-protein signaling, coupled to cGMP nucleotide second messenger | 8.459982e-3 |
GO:0051315 | attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation | 8.518700e-3 |
GO:0046833 | positive regulation of RNA export from nucleus | 8.518700e-3 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 8.545553e-3 |
GO:0035966 | response to topologically incorrect protein | 8.560258e-3 |
GO:0042074 | cell migration involved in gastrulation | 8.645680e-3 |
GO:0010543 | regulation of platelet activation | 8.720153e-3 |
GO:0030917 | midbrain-hindbrain boundary development | 8.847144e-3 |
GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 8.905286e-3 |
GO:0046292 | formaldehyde metabolic process | 8.990113e-3 |
GO:0006984 | ER-nucleus signaling pathway | 8.990515e-3 |
GO:0008535 | respiratory chain complex IV assembly | 9.385236e-3 |
GO:0042354 | L-fucose metabolic process | 9.387117e-3 |
GO:0034214 | protein hexamerization | 9.608684e-3 |
GO:0006004 | fucose metabolic process | 9.659156e-3 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 9.673871e-3 |
GO:0002149 | hypochlorous acid biosynthetic process | 9.702666e-3 |
GO:0032851 | positive regulation of Rab GTPase activity | 9.761752e-3 |
GO:0016139 | glycoside catabolic process | 1.006880e-2 |
GO:0014816 | satellite cell differentiation | 1.010874e-2 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 1.016056e-2 |
GO:0030851 | granulocyte differentiation | 1.022349e-2 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 1.028448e-2 |
GO:0048102 | autophagic cell death | 1.031110e-2 |
GO:0007051 | spindle organization | 1.032990e-2 |
GO:0060712 | spongiotrophoblast layer development | 1.034895e-2 |
GO:0060708 | spongiotrophoblast differentiation | 1.054840e-2 |
GO:0003149 | membranous septum morphogenesis | 1.076737e-2 |
GO:0051583 | dopamine uptake | 1.076737e-2 |
GO:0060574 | intestinal epithelial cell maturation | 1.101360e-2 |
GO:0035425 | autocrine signaling | 1.101360e-2 |
GO:0021501 | prechordal plate formation | 1.101360e-2 |
GO:0021547 | midbrain-hindbrain boundary initiation | 1.101360e-2 |
GO:0009448 | gamma-aminobutyric acid metabolic process | 1.116003e-2 |
GO:0002293 | alpha-beta T cell differentiation involved in immune response | 1.128634e-2 |
GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion | 1.130157e-2 |
GO:0035054 | embryonic heart tube anterior/posterior pattern specification | 1.140066e-2 |
GO:0046100 | hypoxanthine metabolic process | 1.142998e-2 |
GO:0042093 | T-helper cell differentiation | 1.156348e-2 |
GO:2000272 | negative regulation of receptor activity | 1.169096e-2 |
GO:0045090 | retroviral genome replication | 1.180107e-2 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 1.180107e-2 |
GO:0043973 | histone H3-K4 acetylation | 1.180107e-2 |
GO:0060003 | copper ion export | 1.180107e-2 |
GO:0015677 | copper ion import | 1.180107e-2 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 1.180107e-2 |
GO:0006408 | snRNA export from nucleus | 1.180107e-2 |
GO:0006913 | nucleocytoplasmic transport | 1.194632e-2 |
GO:0021535 | cell migration in hindbrain | 1.200550e-2 |
GO:0070734 | histone H3-K27 methylation | 1.224462e-2 |
GO:0006825 | copper ion transport | 1.233919e-2 |
GO:0018022 | peptidyl-lysine methylation | 1.251291e-2 |
GO:0045776 | negative regulation of blood pressure | 1.251765e-2 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 1.269888e-2 |
GO:0050973 | detection of mechanical stimulus involved in equilibrioception | 1.273408e-2 |
GO:0010760 | negative regulation of macrophage chemotaxis | 1.273408e-2 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 1.291314e-2 |
GO:0052314 | phytoalexin metabolic process | 1.306300e-2 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 1.306300e-2 |
GO:0060999 | positive regulation of dendritic spine development | 1.321710e-2 |
GO:0008156 | negative regulation of DNA replication | 1.324248e-2 |
GO:0060561 | apoptosis involved in morphogenesis | 1.326499e-2 |
GO:0009312 | oligosaccharide biosynthetic process | 1.328754e-2 |
GO:0006479 | protein methylation | 1.333132e-2 |
GO:0015917 | aminophospholipid transport | 1.344075e-2 |
GO:0060084 | synaptic transmission involved in micturition | 1.349749e-2 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 1.367588e-2 |
GO:0009817 | defense response to fungus, incompatible interaction | 1.367588e-2 |
GO:0032261 | purine nucleotide salvage | 1.369111e-2 |
GO:0042481 | regulation of odontogenesis | 1.411258e-2 |
GO:0000022 | mitotic spindle elongation | 1.411600e-2 |
GO:0060580 | ventral spinal cord interneuron fate determination | 1.413809e-2 |
GO:0046416 | D-amino acid metabolic process | 1.413809e-2 |
GO:0006384 | transcription initiation from RNA polymerase III promoter | 1.413809e-2 |
GO:0003327 | type B pancreatic cell fate commitment | 1.413809e-2 |
GO:0046730 | induction of host immune response by virus | 1.440430e-2 |
GO:0016226 | iron-sulfur cluster assembly | 1.445466e-2 |
GO:0051036 | regulation of endosome size | 1.455067e-2 |
GO:0010523 | negative regulation of calcium ion transport into cytosol | 1.458872e-2 |
GO:0032096 | negative regulation of response to food | 1.470272e-2 |
GO:0090241 | negative regulation of histone H4 acetylation | 1.511209e-2 |
GO:0018342 | protein prenylation | 1.511209e-2 |
GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion | 1.511209e-2 |
GO:0006403 | RNA localization | 1.515900e-2 |
GO:0090311 | regulation of protein deacetylation | 1.535831e-2 |
GO:0042373 | vitamin K metabolic process | 1.563800e-2 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 1.563800e-2 |
GO:0048268 | clathrin coat assembly | 1.567426e-2 |
GO:2000978 | negative regulation of forebrain neuron differentiation | 1.574964e-2 |
GO:2000227 | negative regulation of pancreatic A cell differentiation | 1.574964e-2 |
GO:0061106 | negative regulation of stomach neuroendocrine cell differentiation | 1.574964e-2 |
GO:0046331 | lateral inhibition | 1.574964e-2 |
GO:0019693 | ribose phosphate metabolic process | 1.578348e-2 |
GO:0002027 | regulation of heart rate | 1.579693e-2 |
GO:0021557 | oculomotor nerve development | 1.591893e-2 |
GO:0006285 | base-excision repair, AP site formation | 1.603008e-2 |
GO:0061303 | cornea development in camera-type eye | 1.603008e-2 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.627459e-2 |
GO:0001302 | replicative cell aging | 1.639909e-2 |
GO:0071843 | cellular component biogenesis at cellular level | 1.642529e-2 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.653115e-2 |
GO:0050774 | negative regulation of dendrite morphogenesis | 1.663550e-2 |
GO:0060670 | branching involved in embryonic placenta morphogenesis | 1.664863e-2 |
GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 1.667065e-2 |
GO:0002827 | positive regulation of T-helper 1 type immune response | 1.675072e-2 |
GO:0070317 | negative regulation of G0 to G1 transition | 1.675610e-2 |
GO:0051754 | meiotic sister chromatid cohesion, centromeric | 1.675610e-2 |
GO:0006747 | FAD biosynthetic process | 1.675610e-2 |
GO:0043610 | regulation of carbohydrate utilization | 1.675610e-2 |
GO:0046605 | regulation of centrosome cycle | 1.688011e-2 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.712176e-2 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 1.717054e-2 |
GO:2000744 | positive regulation of anterior head development | 1.743469e-2 |
GO:0042026 | protein refolding | 1.760442e-2 |
GO:0044088 | regulation of vacuole organization | 1.762771e-2 |
GO:0042109 | lymphotoxin A biosynthetic process | 1.762771e-2 |
GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus | 1.762771e-2 |
GO:0060220 | camera-type eye photoreceptor cell fate commitment | 1.769593e-2 |
GO:0048074 | negative regulation of eye pigmentation | 1.769593e-2 |
GO:0046670 | positive regulation of retinal cell programmed cell death | 1.769593e-2 |
GO:0002534 | cytokine production involved in inflammatory response | 1.769593e-2 |
GO:0034276 | kynurenic acid biosynthetic process | 1.769593e-2 |
GO:0045351 | type I interferon biosynthetic process | 1.783912e-2 |
GO:0050855 | regulation of B cell receptor signaling pathway | 1.786034e-2 |
GO:0032049 | cardiolipin biosynthetic process | 1.786034e-2 |
GO:0035873 | lactate transmembrane transport | 1.786034e-2 |
GO:0060575 | intestinal epithelial cell differentiation | 1.820275e-2 |
GO:0051788 | response to misfolded protein | 1.820937e-2 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 1.824515e-2 |
GO:0060534 | trachea cartilage development | 1.833330e-2 |
GO:0019322 | pentose biosynthetic process | 1.833330e-2 |
GO:0021558 | trochlear nerve development | 1.834805e-2 |
GO:2000114 | regulation of establishment of cell polarity | 1.853011e-2 |
GO:0042407 | cristae formation | 1.899720e-2 |
GO:0046690 | response to tellurium ion | 1.899720e-2 |
GO:0031627 | telomeric loop formation | 1.899720e-2 |
GO:0060086 | circadian temperature homeostasis | 1.899720e-2 |
GO:0051791 | medium-chain fatty acid metabolic process | 1.899720e-2 |
GO:0031119 | tRNA pseudouridine synthesis | 1.899720e-2 |
GO:0006231 | dTMP biosynthetic process | 1.899720e-2 |
GO:0006741 | NADP biosynthetic process | 1.899720e-2 |
GO:0019088 | immortalization of host cell by virus | 1.899720e-2 |
GO:0009645 | response to low light intensity stimulus | 1.899720e-2 |
GO:0070918 | production of small RNA involved in gene silencing by RNA | 1.915049e-2 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 1.918720e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0016072 | rRNA metabolic process | 4.910642e-10 |
GO:0070925 | organelle assembly | 1.954869e-9 |
GO:0042254 | ribosome biogenesis | 2.741363e-9 |
GO:0006364 | rRNA processing | 1.094924e-8 |
GO:0007264 | small GTPase mediated signal transduction | 7.018086e-8 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.823233e-7 |
GO:0035306 | positive regulation of dephosphorylation | 2.302616e-7 |
GO:0000183 | chromatin silencing at rDNA | 2.935813e-7 |
GO:0015876 | acetyl-CoA transport | 3.145851e-7 |
GO:0006427 | histidyl-tRNA aminoacylation | 3.295844e-7 |
GO:0033239 | negative regulation of cellular amine metabolic process | 6.315360e-7 |
GO:0018023 | peptidyl-lysine trimethylation | 6.355560e-7 |
GO:0042053 | regulation of dopamine metabolic process | 7.260367e-7 |
GO:0048332 | mesoderm morphogenesis | 1.235739e-6 |
GO:0022613 | ribonucleoprotein complex biogenesis | 2.231676e-6 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 2.363181e-6 |
GO:0043314 | negative regulation of neutrophil degranulation | 2.744861e-6 |
GO:0006438 | valyl-tRNA aminoacylation | 2.930129e-6 |
GO:0042069 | regulation of catecholamine metabolic process | 3.440931e-6 |
GO:0044260 | cellular macromolecule metabolic process | 3.587231e-6 |
GO:0035441 | cell migration involved in vasculogenesis | 3.610838e-6 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 3.610838e-6 |
GO:0015780 | nucleotide-sugar transport | 4.442713e-6 |
GO:0006188 | IMP biosynthetic process | 6.261475e-6 |
GO:0016574 | histone ubiquitination | 6.282367e-6 |
GO:0006401 | RNA catabolic process | 6.305005e-6 |
GO:0043301 | negative regulation of leukocyte degranulation | 7.192517e-6 |
GO:0031167 | rRNA methylation | 8.301446e-6 |
GO:0031577 | spindle checkpoint | 9.027751e-6 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 9.533266e-6 |
GO:0045875 | negative regulation of sister chromatid cohesion | 9.683002e-6 |
GO:0009113 | purine base biosynthetic process | 1.202324e-5 |
GO:0033238 | regulation of cellular amine metabolic process | 1.252858e-5 |
GO:0035372 | protein localization to microtubule | 1.345586e-5 |
GO:0000045 | autophagic vacuole assembly | 1.426366e-5 |
GO:0006342 | chromatin silencing | 1.468661e-5 |
GO:0031023 | microtubule organizing center organization | 1.854595e-5 |
GO:0001840 | neural plate development | 2.070109e-5 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 2.202414e-5 |
GO:0071843 | cellular component biogenesis at cellular level | 2.248980e-5 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 2.344851e-5 |
GO:0034508 | centromere complex assembly | 2.698703e-5 |
GO:0043313 | regulation of neutrophil degranulation | 3.087460e-5 |
GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 3.174276e-5 |
GO:0042147 | retrograde transport, endosome to Golgi | 4.145271e-5 |
GO:0045814 | negative regulation of gene expression, epigenetic | 4.165298e-5 |
GO:0000154 | rRNA modification | 4.459486e-5 |
GO:0016075 | rRNA catabolic process | 4.549605e-5 |
GO:0042996 | regulation of Golgi to plasma membrane protein transport | 4.585241e-5 |
GO:0035562 | negative regulation of chromatin binding | 4.585241e-5 |
GO:0030970 | retrograde protein transport, ER to cytosol | 5.563568e-5 |
GO:0007098 | centrosome cycle | 5.573379e-5 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 6.031532e-5 |
GO:0016191 | synaptic vesicle uncoating | 6.031532e-5 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 6.284224e-5 |
GO:0060299 | negative regulation of sarcomere organization | 6.284224e-5 |
GO:0034660 | ncRNA metabolic process | 6.314684e-5 |
GO:0050775 | positive regulation of dendrite morphogenesis | 7.205798e-5 |
GO:0043624 | cellular protein complex disassembly | 7.765637e-5 |
GO:0071034 | CUT catabolic process | 8.202182e-5 |
GO:0043241 | protein complex disassembly | 8.212250e-5 |
GO:0071173 | spindle assembly checkpoint | 8.473939e-5 |
GO:0035304 | regulation of protein dephosphorylation | 9.511029e-5 |
GO:0017148 | negative regulation of translation | 9.846985e-5 |
GO:0034470 | ncRNA processing | 1.098795e-4 |
GO:0050668 | positive regulation of homocysteine metabolic process | 1.157541e-4 |
GO:0045963 | negative regulation of dopamine metabolic process | 1.157541e-4 |
GO:0006402 | mRNA catabolic process | 1.258404e-4 |
GO:0001707 | mesoderm formation | 1.298838e-4 |
GO:0018205 | peptidyl-lysine modification | 1.352181e-4 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.360171e-4 |
GO:0051176 | positive regulation of sulfur metabolic process | 1.365167e-4 |
GO:0016559 | peroxisome fission | 1.441022e-4 |
GO:0034661 | ncRNA catabolic process | 1.490065e-4 |
GO:0070079 | histone H4-R3 demethylation | 1.512971e-4 |
GO:0070078 | histone H3-R2 demethylation | 1.512971e-4 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 1.512971e-4 |
GO:0046605 | regulation of centrosome cycle | 1.606366e-4 |
GO:0051297 | centrosome organization | 1.661828e-4 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 1.678572e-4 |
GO:0023019 | signal transduction involved in regulation of gene expression | 1.702385e-4 |
GO:0000910 | cytokinesis | 1.871607e-4 |
GO:0006184 | GTP catabolic process | 1.882751e-4 |
GO:0080164 | regulation of nitric oxide metabolic process | 1.977643e-4 |
GO:0046112 | nucleobase biosynthetic process | 1.980403e-4 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 2.207977e-4 |
GO:2000300 | regulation of synaptic vesicle exocytosis | 2.213905e-4 |
GO:0006189 | 'de novo' IMP biosynthetic process | 2.267829e-4 |
GO:0046039 | GTP metabolic process | 2.317894e-4 |
GO:0090304 | nucleic acid metabolic process | 2.322565e-4 |
GO:0022411 | cellular component disassembly | 2.386070e-4 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 2.430789e-4 |
GO:0006396 | RNA processing | 2.490834e-4 |
GO:0071845 | cellular component disassembly at cellular level | 2.546125e-4 |
GO:0022038 | corpus callosum development | 2.644859e-4 |
GO:0034227 | tRNA thio-modification | 2.889349e-4 |
GO:0046599 | regulation of centriole replication | 2.926407e-4 |
GO:0032984 | macromolecular complex disassembly | 2.935256e-4 |
GO:0034623 | cellular macromolecular complex disassembly | 3.038429e-4 |
GO:0016236 | macroautophagy | 3.101682e-4 |
GO:0051301 | cell division | 3.307537e-4 |
GO:0006886 | intracellular protein transport | 3.315288e-4 |
GO:0002098 | tRNA wobble uridine modification | 3.381917e-4 |
GO:0006481 | C-terminal protein methylation | 3.509590e-4 |
GO:0051586 | positive regulation of dopamine uptake | 3.551433e-4 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 3.653558e-4 |
GO:0007099 | centriole replication | 3.751220e-4 |
GO:0006499 | N-terminal protein myristoylation | 3.809102e-4 |
GO:0002730 | regulation of dendritic cell cytokine production | 3.809102e-4 |
GO:0001839 | neural plate morphogenesis | 3.869967e-4 |
GO:0035494 | SNARE complex disassembly | 4.000603e-4 |
GO:0043538 | regulation of actin phosphorylation | 4.000603e-4 |
GO:0010807 | regulation of synaptic vesicle priming | 4.000603e-4 |
GO:0060696 | regulation of phospholipid catabolic process | 4.180560e-4 |
GO:0035024 | negative regulation of Rho protein signal transduction | 4.282293e-4 |
GO:0046499 | S-adenosylmethioninamine metabolic process | 4.593985e-4 |
GO:0014912 | negative regulation of smooth muscle cell migration | 4.660978e-4 |
GO:0007183 | SMAD protein complex assembly | 4.702159e-4 |
GO:0018022 | peptidyl-lysine methylation | 4.825342e-4 |
GO:0018105 | peptidyl-serine phosphorylation | 4.831587e-4 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 4.885782e-4 |
GO:0034067 | protein localization in Golgi apparatus | 4.944364e-4 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 4.952900e-4 |
GO:0006391 | transcription initiation from mitochondrial promoter | 5.279468e-4 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 5.379148e-4 |
GO:0007498 | mesoderm development | 5.521692e-4 |
GO:0031508 | centromeric heterochromatin formation | 5.661088e-4 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 6.169155e-4 |
GO:0000266 | mitochondrial fission | 6.257016e-4 |
GO:0016082 | synaptic vesicle priming | 6.349012e-4 |
GO:0006415 | translational termination | 6.349012e-4 |
GO:0060005 | vestibular reflex | 6.769273e-4 |
GO:0010467 | gene expression | 7.156470e-4 |
GO:0061302 | smooth muscle cell-matrix adhesion | 7.536724e-4 |
GO:0033566 | gamma-tubulin complex localization | 7.536724e-4 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.660335e-4 |
GO:0051182 | coenzyme transport | 7.683182e-4 |
GO:0006658 | phosphatidylserine metabolic process | 7.752565e-4 |
GO:0061084 | negative regulation of protein refolding | 7.910801e-4 |
GO:0045759 | negative regulation of action potential | 7.910801e-4 |
GO:0090231 | regulation of spindle checkpoint | 8.257482e-4 |
GO:0008272 | sulfate transport | 8.286137e-4 |
GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway | 8.886154e-4 |
GO:0009817 | defense response to fungus, incompatible interaction | 8.886154e-4 |
GO:0010722 | regulation of ferrochelatase activity | 8.886154e-4 |
GO:0070535 | histone H2A K63-linked ubiquitination | 8.950274e-4 |
GO:0016142 | O-glycoside catabolic process | 8.950274e-4 |
GO:0008104 | protein localization | 9.465319e-4 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 9.609363e-4 |
GO:0072355 | histone H3-T3 phosphorylation | 9.620903e-4 |
GO:0033314 | mitotic cell cycle DNA replication checkpoint | 9.620903e-4 |
GO:0001579 | medium-chain fatty acid transport | 9.620903e-4 |
GO:0016070 | RNA metabolic process | 9.703186e-4 |
GO:0061153 | trachea gland development | 1.001590e-3 |
GO:0048069 | eye pigmentation | 1.001590e-3 |
GO:0019049 | evasion of host defenses by virus | 1.029891e-3 |
GO:0010936 | negative regulation of macrophage cytokine production | 1.029891e-3 |
GO:0046782 | regulation of viral transcription | 1.033391e-3 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 1.042221e-3 |
GO:0050434 | positive regulation of viral transcription | 1.043877e-3 |
GO:0071895 | odontoblast differentiation | 1.095451e-3 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 1.134471e-3 |
GO:0070303 | negative regulation of stress-activated protein kinase signaling cascade | 1.164564e-3 |
GO:0060579 | ventral spinal cord interneuron fate commitment | 1.165206e-3 |
GO:0048285 | organelle fission | 1.172172e-3 |
GO:0045792 | negative regulation of cell size | 1.268160e-3 |
GO:0032319 | regulation of Rho GTPase activity | 1.292335e-3 |
GO:0060492 | lung induction | 1.309538e-3 |
GO:0060244 | negative regulation of cell proliferation involved in contact inhibition | 1.309538e-3 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 1.331310e-3 |
GO:0022007 | convergent extension involved in neural plate elongation | 1.360703e-3 |
GO:0007051 | spindle organization | 1.416568e-3 |
GO:0021570 | rhombomere 4 development | 1.418466e-3 |
GO:0021861 | forebrain radial glial cell differentiation | 1.445355e-3 |
GO:0006412 | translation | 1.546631e-3 |
GO:0046329 | negative regulation of JNK cascade | 1.557358e-3 |
GO:0043201 | response to leucine | 1.585660e-3 |
GO:0030719 | P granule organization | 1.585660e-3 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 1.586262e-3 |
GO:0044265 | cellular macromolecule catabolic process | 1.597101e-3 |
GO:0000042 | protein targeting to Golgi | 1.612562e-3 |
GO:0015031 | protein transport | 1.617661e-3 |
GO:0032077 | positive regulation of deoxyribonuclease activity | 1.667833e-3 |
GO:0071711 | basement membrane organization | 1.673122e-3 |
GO:0032530 | regulation of microvillus organization | 1.730143e-3 |
GO:0002074 | extraocular skeletal muscle development | 1.730143e-3 |
GO:0021571 | rhombomere 5 development | 1.773801e-3 |
GO:0009057 | macromolecule catabolic process | 1.776575e-3 |
GO:0030223 | neutrophil differentiation | 1.932548e-3 |
GO:0061381 | cell migration in diencephalon | 1.952878e-3 |
GO:0061379 | inferior colliculus development | 1.952878e-3 |
GO:0021855 | hypothalamus cell migration | 1.952878e-3 |
GO:0061374 | mammillothalamic axonal tract development | 1.952878e-3 |
GO:0008637 | apoptotic mitochondrial changes | 1.986221e-3 |
GO:0090199 | regulation of release of cytochrome c from mitochondria | 2.070877e-3 |
GO:0006139 | nucleobase-containing compound metabolic process | 2.071860e-3 |
GO:0071294 | cellular response to zinc ion | 2.144036e-3 |
GO:0033590 | response to cobalamin | 2.165720e-3 |
GO:0006601 | creatine biosynthetic process | 2.165720e-3 |
GO:0034314 | Arp2/3 complex-mediated actin nucleation | 2.266262e-3 |
GO:0045175 | basal protein localization | 2.266262e-3 |
GO:0031584 | activation of phospholipase D activity | 2.285305e-3 |
GO:0031055 | chromatin remodeling at centromere | 2.285305e-3 |
GO:0006829 | zinc ion transport | 2.348511e-3 |
GO:0002534 | cytokine production involved in inflammatory response | 2.431501e-3 |
GO:0034276 | kynurenic acid biosynthetic process | 2.431501e-3 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 2.431501e-3 |
GO:0035115 | embryonic forelimb morphogenesis | 2.561071e-3 |
GO:0034379 | very-low-density lipoprotein particle assembly | 2.569875e-3 |
GO:0010822 | positive regulation of mitochondrion organization | 2.572030e-3 |
GO:0033522 | histone H2A ubiquitination | 2.573102e-3 |
GO:0007266 | Rho protein signal transduction | 2.614280e-3 |
GO:0006493 | protein O-linked glycosylation | 2.715498e-3 |
GO:0051298 | centrosome duplication | 2.743517e-3 |
GO:0000301 | retrograde transport, vesicle recycling within Golgi | 2.743517e-3 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 2.759526e-3 |
GO:0009264 | deoxyribonucleotide catabolic process | 2.759526e-3 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 2.869436e-3 |
GO:0043632 | modification-dependent macromolecule catabolic process | 2.883008e-3 |
GO:0019941 | modification-dependent protein catabolic process | 3.011613e-3 |
GO:0032321 | positive regulation of Rho GTPase activity | 3.055720e-3 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 3.114854e-3 |
GO:0021569 | rhombomere 3 development | 3.147225e-3 |
GO:0060367 | sagittal suture morphogenesis | 3.183655e-3 |
GO:0060873 | anterior semicircular canal development | 3.183655e-3 |
GO:0070242 | thymocyte apoptosis | 3.183655e-3 |
GO:0060875 | lateral semicircular canal development | 3.183655e-3 |
GO:0060366 | lambdoid suture morphogenesis | 3.183655e-3 |
GO:0051382 | kinetochore assembly | 3.183655e-3 |
GO:0035520 | monoubiquitinated protein deubiquitination | 3.183655e-3 |
GO:0022018 | lateral ganglionic eminence cell proliferation | 3.183655e-3 |
GO:0035553 | oxidative single-stranded RNA demethylation | 3.183655e-3 |
GO:0048340 | paraxial mesoderm morphogenesis | 3.303039e-3 |
GO:0071480 | cellular response to gamma radiation | 3.354975e-3 |
GO:0009262 | deoxyribonucleotide metabolic process | 3.433572e-3 |
GO:0060364 | frontal suture morphogenesis | 3.440003e-3 |
GO:0010824 | regulation of centrosome duplication | 3.440003e-3 |
GO:0060461 | right lung morphogenesis | 3.524846e-3 |
GO:0090131 | mesenchyme migration | 3.524846e-3 |
GO:0014822 | detection of wounding | 3.524846e-3 |
GO:0060446 | branching involved in open tracheal system development | 3.524846e-3 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 3.524846e-3 |
GO:0042492 | gamma-delta T cell differentiation | 3.524846e-3 |
GO:0048371 | lateral mesodermal cell differentiation | 3.524846e-3 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 3.569998e-3 |
GO:0018364 | peptidyl-glutamine methylation | 3.569998e-3 |
GO:0070831 | basement membrane assembly | 3.569998e-3 |
GO:0016569 | covalent chromatin modification | 3.632963e-3 |
GO:0010452 | histone H3-K36 methylation | 3.670006e-3 |
GO:0021986 | habenula development | 3.677297e-3 |
GO:0040015 | negative regulation of multicellular organism growth | 3.741796e-3 |
GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development | 3.820476e-3 |
GO:0032922 | circadian regulation of gene expression | 3.822221e-3 |
GO:0008078 | mesodermal cell migration | 3.825777e-3 |
GO:0008654 | phospholipid biosynthetic process | 3.838273e-3 |
GO:0071168 | protein localization to chromatin | 3.854017e-3 |
GO:0051299 | centrosome separation | 3.854017e-3 |
GO:0046426 | negative regulation of JAK-STAT cascade | 4.175754e-3 |
GO:0070534 | protein K63-linked ubiquitination | 4.400454e-3 |
GO:0002829 | negative regulation of type 2 immune response | 4.478258e-3 |
GO:0043949 | regulation of cAMP-mediated signaling | 4.549754e-3 |
GO:0010950 | positive regulation of endopeptidase activity | 4.556355e-3 |
GO:0021542 | dentate gyrus development | 4.605938e-3 |
GO:0014819 | regulation of skeletal muscle contraction | 4.844314e-3 |
GO:0008612 | peptidyl-lysine modification to hypusine | 4.845381e-3 |
GO:0014910 | regulation of smooth muscle cell migration | 4.860839e-3 |
GO:0035404 | histone-serine phosphorylation | 4.914970e-3 |
GO:0060236 | regulation of mitotic spindle organization | 4.949321e-3 |
GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway | 4.949321e-3 |
GO:0006778 | porphyrin-containing compound metabolic process | 4.982940e-3 |
GO:0002719 | negative regulation of cytokine production involved in immune response | 4.984129e-3 |
GO:0014745 | negative regulation of muscle adaptation | 5.008155e-3 |
GO:0043610 | regulation of carbohydrate utilization | 5.140088e-3 |
GO:2000781 | positive regulation of double-strand break repair | 5.140088e-3 |
GO:0070922 | small RNA loading onto RISC | 5.140088e-3 |
GO:0019047 | provirus integration | 5.140088e-3 |
GO:0016140 | O-glycoside metabolic process | 5.140088e-3 |
GO:0048741 | skeletal muscle fiber development | 5.192851e-3 |
GO:0030219 | megakaryocyte differentiation | 5.264386e-3 |
GO:0045184 | establishment of protein localization | 5.285864e-3 |
GO:0035617 | stress granule disassembly | 5.357587e-3 |
GO:0032074 | negative regulation of nuclease activity | 5.357587e-3 |
GO:0016570 | histone modification | 5.384600e-3 |
GO:0021521 | ventral spinal cord interneuron specification | 5.460131e-3 |
GO:0007049 | cell cycle | 5.650914e-3 |
GO:0010172 | embryonic body morphogenesis | 5.738178e-3 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 5.834157e-3 |
GO:0016573 | histone acetylation | 5.862385e-3 |
GO:0007063 | regulation of sister chromatid cohesion | 5.923307e-3 |
GO:0006659 | phosphatidylserine biosynthetic process | 5.986888e-3 |
GO:0060242 | contact inhibition | 6.074014e-3 |
GO:0021771 | lateral geniculate nucleus development | 6.078040e-3 |
GO:0003026 | regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback | 6.078040e-3 |
GO:0018065 | protein-cofactor linkage | 6.263376e-3 |
GO:0006914 | autophagy | 6.325120e-3 |
GO:0021514 | ventral spinal cord interneuron differentiation | 6.394515e-3 |
GO:0021776 | smoothened signaling pathway involved in spinal cord motor neuron cell fate specification | 6.413017e-3 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 6.413017e-3 |
GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification | 6.413017e-3 |
GO:0002513 | tolerance induction to self antigen | 6.413017e-3 |
GO:0006611 | protein export from nucleus | 6.458454e-3 |
GO:0048341 | paraxial mesoderm formation | 6.553318e-3 |
GO:0006783 | heme biosynthetic process | 6.737874e-3 |
GO:0032508 | DNA duplex unwinding | 6.876061e-3 |
GO:0010799 | regulation of peptidyl-threonine phosphorylation | 7.424339e-3 |
GO:0033127 | regulation of histone phosphorylation | 7.531872e-3 |
GO:0051900 | regulation of mitochondrial depolarization | 7.627549e-3 |
GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter | 7.721060e-3 |
GO:0016584 | nucleosome positioning | 7.809003e-3 |
GO:0048293 | regulation of isotype switching to IgE isotypes | 7.827585e-3 |
GO:0007031 | peroxisome organization | 7.930029e-3 |
GO:0046474 | glycerophospholipid biosynthetic process | 7.932390e-3 |
GO:0051901 | positive regulation of mitochondrial depolarization | 8.017709e-3 |
GO:0046580 | negative regulation of Ras protein signal transduction | 8.035818e-3 |
GO:0034645 | cellular macromolecule biosynthetic process | 8.243827e-3 |
GO:0051983 | regulation of chromosome segregation | 8.314894e-3 |
GO:0048339 | paraxial mesoderm development | 8.326880e-3 |
GO:0042245 | RNA repair | 8.446635e-3 |
GO:0071712 | ER-associated misfolded protein catabolic process | 8.446635e-3 |
GO:0003329 | pancreatic PP cell fate commitment | 8.446635e-3 |
GO:0003326 | pancreatic A cell fate commitment | 8.446635e-3 |
GO:0045905 | positive regulation of translational termination | 8.470051e-3 |
GO:0045901 | positive regulation of translational elongation | 8.470051e-3 |
GO:0006452 | translational frameshifting | 8.470051e-3 |
GO:0021513 | spinal cord dorsal/ventral patterning | 8.493347e-3 |
GO:0045647 | negative regulation of erythrocyte differentiation | 8.569771e-3 |
GO:0006824 | cobalt ion transport | 8.617395e-3 |
GO:0032392 | DNA geometric change | 8.882367e-3 |
GO:0032264 | IMP salvage | 9.032806e-3 |
GO:0032263 | GMP salvage | 9.032806e-3 |
GO:0046038 | GMP catabolic process | 9.032806e-3 |
GO:0048633 | positive regulation of skeletal muscle tissue growth | 9.032806e-3 |
GO:0010825 | positive regulation of centrosome duplication | 9.032806e-3 |
GO:0006178 | guanine salvage | 9.032806e-3 |
GO:0006713 | glucocorticoid catabolic process | 9.032806e-3 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 9.105094e-3 |
GO:0051573 | negative regulation of histone H3-K9 methylation | 9.245246e-3 |
GO:0021612 | facial nerve structural organization | 9.245246e-3 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 9.269814e-3 |
GO:0045063 | T-helper 1 cell differentiation | 9.269814e-3 |
GO:0030885 | regulation of myeloid dendritic cell activation | 9.318085e-3 |
GO:0034776 | response to histamine | 9.318085e-3 |
GO:0035470 | positive regulation of vascular wound healing | 9.318085e-3 |
GO:0018293 | protein-FAD linkage | 9.318085e-3 |
GO:0015761 | mannose transport | 9.318085e-3 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 9.318085e-3 |
GO:0009234 | menaquinone biosynthetic process | 9.318085e-3 |
GO:0010616 | negative regulation of cardiac muscle adaptation | 9.318085e-3 |
GO:0007028 | cytoplasm organization | 9.340922e-3 |
GO:0021511 | spinal cord patterning | 9.505704e-3 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 1.002413e-2 |
GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity | 1.004803e-2 |
GO:0016558 | protein import into peroxisome matrix | 1.006364e-2 |
GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 1.010776e-2 |
GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process | 1.059474e-2 |
GO:0032713 | negative regulation of interleukin-4 production | 1.065444e-2 |
GO:0071422 | succinate transmembrane transport | 1.075125e-2 |
GO:0001830 | trophectodermal cell fate commitment | 1.075125e-2 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 1.075125e-2 |
GO:0021562 | vestibulocochlear nerve development | 1.080744e-2 |
GO:0016071 | mRNA metabolic process | 1.102729e-2 |
GO:0002701 | negative regulation of production of molecular mediator of immune response | 1.113776e-2 |
GO:0014040 | positive regulation of Schwann cell differentiation | 1.114081e-2 |
GO:0051383 | kinetochore organization | 1.114081e-2 |
GO:0010388 | cullin deneddylation | 1.196441e-2 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 1.205478e-2 |
GO:0021943 | formation of radial glial scaffolds | 1.206466e-2 |
GO:0030336 | negative regulation of cell migration | 1.210423e-2 |
GO:0051225 | spindle assembly | 1.210679e-2 |
GO:0033013 | tetrapyrrole metabolic process | 1.225823e-2 |
GO:0051567 | histone H3-K9 methylation | 1.233203e-2 |
GO:0045292 | nuclear mRNA cis splicing, via spliceosome | 1.236758e-2 |
GO:0009143 | nucleoside triphosphate catabolic process | 1.240140e-2 |
GO:0071218 | cellular response to misfolded protein | 1.246549e-2 |
GO:0048246 | macrophage chemotaxis | 1.249782e-2 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.252538e-2 |
GO:0021506 | anterior neuropore closure | 1.252538e-2 |
GO:0007509 | mesoderm migration involved in gastrulation | 1.252538e-2 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 1.264950e-2 |
GO:0000087 | M phase of mitotic cell cycle | 1.269221e-2 |
GO:0016568 | chromatin modification | 1.347590e-2 |
GO:0035967 | cellular response to topologically incorrect protein | 1.357604e-2 |
GO:0032312 | regulation of ARF GTPase activity | 1.357604e-2 |
GO:0071476 | cellular hypotonic response | 1.358881e-2 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 1.365534e-2 |
GO:0046856 | phosphatidylinositol dephosphorylation | 1.368975e-2 |
GO:0060580 | ventral spinal cord interneuron fate determination | 1.385256e-2 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 1.385256e-2 |
GO:0090182 | regulation of secretion of lysosomal enzymes | 1.385256e-2 |
GO:0090186 | regulation of pancreatic juice secretion | 1.385256e-2 |
GO:0051882 | mitochondrial depolarization | 1.385256e-2 |
GO:0003327 | type B pancreatic cell fate commitment | 1.385256e-2 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 1.385256e-2 |
GO:0046079 | dUMP catabolic process | 1.385256e-2 |
GO:0048550 | negative regulation of pinocytosis | 1.385256e-2 |
GO:0031657 | regulation of cyclin-dependent protein kinase activity involved in G1/S | 1.401356e-2 |
GO:0051058 | negative regulation of small GTPase mediated signal transduction | 1.404843e-2 |
GO:0060209 | estrus | 1.406467e-2 |
GO:0090340 | positive regulation of secretion of lysosomal enzymes | 1.406467e-2 |
GO:0090187 | positive regulation of pancreatic juice secretion | 1.406467e-2 |
GO:0090108 | positive regulation of high-density lipoprotein particle assembly | 1.406467e-2 |
GO:0003419 | growth plate cartilage chondrocyte proliferation | 1.406467e-2 |
GO:0035087 | siRNA loading onto RISC involved in RNA interference | 1.406467e-2 |
GO:0043105 | negative regulation of GTP cyclohydrolase I activity | 1.406467e-2 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 1.407933e-2 |
GO:0060124 | positive regulation of growth hormone secretion | 1.417768e-2 |
GO:2000114 | regulation of establishment of cell polarity | 1.417768e-2 |
GO:0018393 | internal peptidyl-lysine acetylation | 1.428648e-2 |
GO:0006325 | chromatin organization | 1.434711e-2 |
GO:0006680 | glucosylceramide catabolic process | 1.440610e-2 |
GO:0021997 | neural plate axis specification | 1.440610e-2 |
GO:0021754 | facial nucleus development | 1.440610e-2 |
GO:0031659 | positive regulation of cyclin-dependent protein kinase activity involved in G1/S | 1.446455e-2 |
GO:0031507 | heterochromatin formation | 1.446455e-2 |
GO:0034968 | histone lysine methylation | 1.447299e-2 |
GO:0009059 | macromolecule biosynthetic process | 1.448491e-2 |
GO:0048066 | developmental pigmentation | 1.450392e-2 |
GO:0030950 | establishment or maintenance of actin cytoskeleton polarity | 1.453504e-2 |
GO:0071477 | cellular hypotonic salinity response | 1.453504e-2 |
GO:0021895 | cerebral cortex neuron differentiation | 1.488214e-2 |
GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning | 1.520873e-2 |
GO:0016926 | protein desumoylation | 1.520873e-2 |
GO:0043988 | histone H3-S28 phosphorylation | 1.521025e-2 |
GO:0051791 | medium-chain fatty acid metabolic process | 1.521025e-2 |
GO:0070625 | zymogen granule exocytosis | 1.521025e-2 |
GO:0043987 | histone H3-S10 phosphorylation | 1.521025e-2 |
GO:0010933 | positive regulation of macrophage tolerance induction | 1.521025e-2 |
GO:0002158 | osteoclast proliferation | 1.521025e-2 |
GO:0034134 | toll-like receptor 2 signaling pathway | 1.521025e-2 |
GO:0007196 | inhibition of adenylate cyclase activity by metabotropic glutamate receptor signaling pathway | 1.521025e-2 |
GO:0015724 | formate transport | 1.521025e-2 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 1.534095e-2 |
GO:0010592 | positive regulation of lamellipodium assembly | 1.548031e-2 |
GO:0009261 | ribonucleotide catabolic process | 1.592606e-2 |
GO:0021783 | preganglionic parasympathetic nervous system development | 1.594631e-2 |
GO:0044257 | cellular protein catabolic process | 1.599118e-2 |
GO:0031536 | positive regulation of exit from mitosis | 1.618726e-2 |
GO:0018394 | peptidyl-lysine acetylation | 1.638676e-2 |
GO:0006268 | DNA unwinding involved in replication | 1.642417e-2 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 1.668598e-2 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 1.672026e-2 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 1.675397e-2 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 1.685762e-2 |
GO:0006449 | regulation of translational termination | 1.685762e-2 |
GO:0007265 | Ras protein signal transduction | 1.699360e-2 |
GO:0010390 | histone monoubiquitination | 1.712954e-2 |
GO:0045017 | glycerolipid biosynthetic process | 1.714526e-2 |
GO:0001574 | ganglioside biosynthetic process | 1.719656e-2 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 1.779806e-2 |
GO:0043966 | histone H3 acetylation | 1.783715e-2 |
GO:2000286 | receptor internalization involved in canonical Wnt receptor signaling pathway | 1.830007e-2 |
GO:0043932 | ossification involved in bone remodeling | 1.830007e-2 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 1.830007e-2 |
GO:0032534 | regulation of microvillus assembly | 1.830007e-2 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 1.830007e-2 |
GO:0070172 | positive regulation of tooth mineralization | 1.837074e-2 |
GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning | 1.837074e-2 |
GO:0051081 | nuclear envelope disassembly | 1.837074e-2 |
GO:0042255 | ribosome assembly | 1.845618e-2 |
GO:0009200 | deoxyribonucleoside triphosphate metabolic process | 1.845618e-2 |
GO:0051351 | positive regulation of ligase activity | 1.847859e-2 |
GO:0060806 | negative regulation of cell differentiation involved in embryonic placenta development | 1.864628e-2 |
GO:0008208 | C21-steroid hormone catabolic process | 1.864628e-2 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 1.870193e-2 |
GO:0043923 | positive regulation by host of viral transcription | 1.876895e-2 |
GO:0033128 | negative regulation of histone phosphorylation | 1.915297e-2 |
GO:0072537 | fibroblast activation | 1.915297e-2 |
GO:0030997 | regulation of centriole-centriole cohesion | 1.915297e-2 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 1.915297e-2 |
GO:0006498 | N-terminal protein lipidation | 1.915297e-2 |
GO:0090076 | relaxation of skeletal muscle | 1.917968e-2 |
GO:0043654 | recognition of apoptotic cell | 1.917968e-2 |
GO:0032470 | elevation of endoplasmic reticulum calcium ion concentration | 1.917968e-2 |
GO:0032872 | regulation of stress-activated MAPK cascade | 1.929091e-2 |
GO:2000146 | negative regulation of cell motility | 1.930922e-2 |
GO:0018410 | C-terminal protein amino acid modification | 1.947235e-2 |
GO:0003218 | cardiac left ventricle formation | 1.951105e-2 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 1.981833e-2 |
GO:0007067 | mitosis | 1.987824e-2 |
GO:0009154 | purine ribonucleotide catabolic process | 1.997617e-2 |
GO:0006260 | DNA replication | 1.999604e-2 |
GO:0046148 | pigment biosynthetic process | 2.005856e-2 |
GO:0030262 | apoptotic nuclear change | 2.038437e-2 |
GO:0071353 | cellular response to interleukin-4 | 2.076744e-2 |
GO:0045920 | negative regulation of exocytosis | 2.088054e-2 |
GO:0021520 | spinal cord motor neuron cell fate specification | 2.088341e-2 |
GO:0016458 | gene silencing | 2.153568e-2 |
GO:2000143 | negative regulation of transcription initiation, DNA-dependent | 2.198370e-2 |
GO:0046323 | glucose import | 2.198370e-2 |
GO:0008105 | asymmetric protein localization | 2.237581e-2 |
GO:0000281 | cytokinesis after mitosis | 2.258400e-2 |
GO:0050774 | negative regulation of dendrite morphogenesis | 2.267423e-2 |
GO:0034142 | toll-like receptor 4 signaling pathway | 2.287646e-2 |
GO:0001845 | phagolysosome assembly | 2.287646e-2 |
GO:0031999 | negative regulation of fatty acid beta-oxidation | 2.287646e-2 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 2.292540e-2 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 2.292540e-2 |
GO:0051775 | response to redox state | 2.300052e-2 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 2.374848e-2 |
GO:0048294 | negative regulation of isotype switching to IgE isotypes | 2.399162e-2 |